Get the latest news and updates from Susan G. Komen

Blog  |  Newsroom

Susan G. Komen® Applauds House Committee for Advancing Key Breast Cancer Legislation That Will Make Breast Health Services More Accessible

Urges Full House Action So Millions Can Get the Critical Care They Need WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, commends members of the U.S. House Energy and Commerce Committee for passing the SCREENS for Cancer Act and the EARLY Act Reauthorization of 2025, an important step in the legislative […]

Susan G. Komen® Advocates for Access to Breast Care Imaging As Voter Support Grows

Breast Cancer Community Urges Action During Annual Advocacy Summit WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, urged lawmakers on Capitol Hill to put their full support behind pending legislation that would expand access to early detection and require insurance companies to fully cover the cost of all recommended breast imaging, […]

Pennsylvania Community Unites at 2026 Susan G. Komen® MORE THAN PINK Walks 

Annual Events Raise Critical Funds for Lifesaving Research, Advocacy and Direct Patient Support, Driving Local Impact PHILADELPHIA – Susan G. Komen®, the world’s leading breast cancer organization, will bring together breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at two Pennsylvania MORE THAN PINK Walks in May. Our community will come together to make sure no one faces breast cancer alone and help advance Komen’s […]

Susan G. Komen® Applauds Introduction of the Breast Cancer Research Stamp Reauthorization Act

Proceeds from Stamp have Funded Nearly $100 Million in Breast Cancer Research WASHINGTON, DC –  Susan G. Komen®, the world’s leading breast cancer organization, applauds the introduction of the Breast Cancer Research Stamp Reauthorization Act of 2026 and urges swift passage to secure continued vital research funds. The legislation, introduced by Senator Jacky Rosen (D-NV), Senator Ashley Moody (R-FL), Representative Beth […]

Susan G. Komen® Urges Congress to Support Critical Breast Cancer Research and Safety Net Programs in FY27 Budget 

Warns Research Cuts in President’s Budget Could Cost Lives  Susan G. Komen®, the world’s leading breast cancer organization, opposes the Trump Administration’s plans to cut $5 billion in funding for vital medical research as part of its proposed fiscal year 2027 (FY27) budget. While Komen is pleased to see that the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), the only option for breast and cervical cancer screening for millions of Americans, would be funded at current levels, more funding is needed to serve all who qualify.   “Komen calls […]

Statement on Passage of Legislation That Increases Access to Oral Chemotherapy Treatments in Idaho

BOISE – Susan G. Komen®, the world’s leading breast cancer organization, commends the passage of legislation that will require individual health insurance plans to cover oral, self-administered anticancer medications on terms no less favorable than the coverage for intravenous (IV), injected, or port-administered therapies. HB 648, sponsored by Rep. Chris Bruce (R – Kuna), will […]

Statement on Passage of Legislation Eliminating Financial Barriers to Critical Breast Imaging in Wisconsin

Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of critical breast imaging legislation in Wisconsin, SB 264 or Gail’s Law. Diagnostic and supplemental imaging are critical forms of breast cancer screening for some high-risk individuals and an important follow-up step in determining the need for a biopsy […]

Statement on Passage of Legislation Increasing Access to Treatments for Metastatic Cancer Patients in Indiana

INDIANAPOLIS, INDIANA – Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of HB 1114, which prohibits the use of step therapy protocols for metastatic cancer patients. Step therapy, also referred to as “fail first,” requires a patient to first try a health plan preferred drug, have that […]

St. Louis Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2026 MORE THAN PINK Walk

Annual Event to Fuel Research Advancements and Strengthen the St. Louis Community with Vital Support Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the St. Louis MORE THAN PINK Walk on Saturday, June 6 in a NEW LOCATION – […]

Columbus Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2026 Race for the Cure

Annual Event to Fuel Research Advancements and Strengthen the Columbus Community with Vital Support Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the Columbus Race for the Cure on Saturday, May 16. This impactful event unites our community and […]

Chicago Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2026 Race for the Cure

Annual Event to Fuel Research Advancements and Strengthen the Chicago Community with Vital Support Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the Chicago Race for the Cure on Saturday, May 16. This impactful event unites our community and […]

Legislation Eliminates Financial Barriers to Critical Breast Imaging, Would Help Thousands Across Kansas Afford Care They Require

Susan G. Komen® Applauds Senate Committee Passage, Urges Swift Floor Vote TOPEKA, KANSAS – Susan G. Komen®, the world’s leading breast cancer organization commends Insurance Commissioner Vicki Schmidt for recently introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening. […]